StockData
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc. (DMAC) stock

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.38+0.05 (+0.60%)

Close on Nov 17, 2026Market cap $451.90MP/E –Yield –

DiaMedica Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for DiaMedica Therapeutics

DiaMedica Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More DiaMedica Therapeutics figures

See a number that looks wrong?